The National Cancer Institute is offering the Pediatric Immunotherapy Translational Science Network Grant as part of the Beau Biden Cancer Moonshot Initiative. This grant aims to establish collaborative Centers to accelerate research in translating immunotherapy concepts for children with cancer. The focus is on identifying new immunotherapy targets, developing pediatric immunotherapy treatment approaches, and understanding how pediatric tumors evade the immune system. The grant will fund initiatives that align with the Blue Ribbon Panel’s recommendation for a pediatric immunotherapy translational science network. Closing date for applications is December 19, 2017.
Opportunity ID: 297681
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-17-050 |
| Funding Opportunity Title: | Pediatric Immunotherapy Translational Science Network (PI-TSN)(U54) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.395 — Cancer Treatment Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 26, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Dec 19, 2017 |
| Current Closing Date for Applications: | Dec 19, 2017 |
| Archive Date: | Jan 24, 2018 |
| Estimated Total Program Funding: | $4,000,000 |
| Award Ceiling: | $1,600,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses State governments County governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Independent school districts Public housing authorities/Indian housing authorities City or township governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to establish Centers of collaborating investigators with the goal of identifying and advancing research opportunities for translating immunotherapy concepts for children and adolescents with cancer toward clinical applications. Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP): Recommendation (B) that calls for the establishment of a pediatric immunotherapy translational science network. The network was envisioned by the BRP as focusing on identifying new targets for immunotherapies, developing new pediatric immunotherapy treatment approaches (e.g., cancer vaccines, cellular therapy, combinations of immunotherapy agents, and others), and defining the biological mechanisms by which pediatric tumors evade the immune system. The Pediatric Immunotherapy Discovery and Development Network (PI-DDN) Centers will address and implement these BRP recommendations. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-17-050.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D | FORMS-D | PKG00234938 | Nov 19, 2017 | Dec 19, 2017 | View |
Package 1
Mandatory forms
297681 RR_SF424_2_0-2.0.pdf
297681 PHS398_CoverPageSupplement_3_0-3.0.pdf
297681 RR_OtherProjectInfo_1_3-1.3.pdf
297681 PerformanceSite_2_0-2.0.pdf
297681 RR_KeyPersonExpanded_2_0-2.0.pdf
297681 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
297681 PHS_Additional_IndirectCosts-1.0.pdf
297681 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
